Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis (Q36554698)

14 August 2017

1 reference

title

Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis (English)

1 reference

14 August 2017

0 references

1 reference

1 reference

Jason A Roberts

1

0 references

author name string

Jeffrey Lipman

series ordinal

2

1 reference

14 August 2017

1 January 2006

1 reference

Clinical Pharmacokinetics

14 August 2017

1 reference

14 August 2017

45

1 reference

14 August 2017

8

1 reference

14 August 2017

755-773

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200645080-00001

14 August 2017

0 references

cites work

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200645080-00001

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200645080-00001

Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200645080-00001

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200645080-00001

Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200645080-00001

Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200645080-00001

Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200645080-00001

Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200645080-00001

A Bayesian feedback method of aminoglycoside dosing.

21 January 2018

1 reference

12 December 2020

Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity

1 reference

12 December 2020

Once versus thrice daily gentamicin in patients with serious infections

1 reference

12 December 2020

Pathogenetic mechanisms of septic shock

1 reference

12 December 2020

Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing

1 reference

12 December 2020

Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers

1 reference

12 December 2020

Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections

1 reference

12 December 2020

Cefepime versus cefpirome: the importance of creatinine clearance

1 reference

12 December 2020

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

1 reference

12 December 2020

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

1 reference

12 December 2020

Efficacy of telavancin (TD-6424), a rapidly bactericidal lipoglycopeptide with multiple mechanisms of action, in a murine model of pneumonia induced by methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Whole-body inflammation in trauma patients. An autopsy study

1 reference

12 December 2020

Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis

1 reference

12 December 2020

Post-antibiotic and post-beta-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum beta-lactamase-producing Gram-negative bacteria

1 reference

12 December 2020

Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model

1 reference

12 December 2020

Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients

1 reference

12 December 2020

Why monitor peak vancomycin concentrations?

1 reference

12 December 2020

Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection.

1 reference

12 December 2020

Generalized vascular permeability and pulmonary function in patients following serious trauma

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion.

1 reference

12 December 2020

The concentration-independent effect of monoexponential and biexponential decay in vancomycin concentrations on the killing of Staphylococcus aureus under aerobic and anaerobic conditions

1 reference

12 December 2020

Therapeutic intervention and targets for sepsis

1 reference

12 December 2020

Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis

1 reference

12 December 2020

Inadequacy of standard aminoglycoside loading doses in acutely ill patients

1 reference

12 December 2020

Aminoglycoside pharmacokinetics: volume of distribution in specific adult patient subgroups

1 reference

12 December 2020

Renal replacement therapy for the critically ill--precarious progress. Part I. Definitions and physiological aspects

1 reference

12 December 2020

Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats

1 reference

12 December 2020

Clinical pharmacokinetics of teicoplanin

1 reference

12 December 2020

Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice

1 reference

12 December 2020

Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.

1 reference

12 December 2020

Removal of imipenem and cilastatin by hemodialysis in patients with end-stage renal failure

1 reference

12 December 2020

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

1 reference

12 December 2020

Pharmacokinetics of drugs used in critically ill adults

1 reference

12 December 2020

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

12 December 2020

Therapeutic monitoring of aminoglycoside antibiotics: an approach.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of fluoroquinolones

1 reference

12 December 2020

Altered aminoglycoside pharmacokinetics in the critically ill

1 reference

12 December 2020

Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers.

1 reference

12 December 2020

Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa

1 reference

12 December 2020

Single or multiple daily doses of aminoglycosides: a meta-analysis

1 reference

12 December 2020

High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.

1 reference

12 December 2020

Antibiotic treatment of sepsis

1 reference

12 December 2020

Kinetics of antimicrobial activity

1 reference

12 December 2020

Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial

1 reference

12 December 2020

Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations.

1 reference

12 December 2020

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

1 reference

12 December 2020

The pharmacology of orally administered ciprofloxacin

1 reference

12 December 2020

Pharmacokinetics of cefepime in patients with the sepsis syndrome

1 reference

12 December 2020

Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection

1 reference

12 December 2020

Therapy of ventilator-associated pneumonia: the Tarragona Strategy

1 reference

12 December 2020

Integration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosa

1 reference

12 December 2020

A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients

1 reference

12 December 2020

The importance of antibiotic pharmacokinetics in critical illness

1 reference

12 December 2020

Experience with a once-daily dosing program of aminoglycosides in critically ill patients

1 reference

12 December 2020

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment

1 reference

12 December 2020

Role for Dual Individualization with Cefmenoxime

1 reference

12 December 2020

Clinical and economic benefits of a meropenem dosage strategy based on pharmacodynamic concepts.

1 reference

12 December 2020

The haemodynamic and metabolic effects of epinephrine in experimental hyperdynamic septic shock

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans

1 reference

12 December 2020

Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia

1 reference

12 December 2020

Prevention of resistance: a goal for dose selection for antimicrobial agents

1 reference

12 December 2020

Antimicrobial prescribing in patients on haemofiltration

1 reference

12 December 2020

Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients

1 reference

12 December 2020

Stability of meropenem in normal saline solution after storage at room temperature.

1 reference

12 December 2020

Once daily aminoglycoside dosing: maintained efficacy with reduced nephrotoxicity?

1 reference

12 December 2020

The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits

1 reference

12 December 2020

Killing and regrowth of bacteria in vitro: a review.

1 reference

12 December 2020

Gentamicin volume of distribution in critically ill septic patients

1 reference

12 December 2020

The pharmacokinetics of intravenous ciprofloxacin 400 mg 12 hourly in patients with severe sepsis: the effect of renal function and intra-abdominal disease

1 reference

12 December 2020

Use of antibacterial agents in renal failure

1 reference

12 December 2020

The in-vivo postantibiotic effect of imipenem and other new antimicrobials

1 reference

12 December 2020

Continuous infusion versus intermittent administration of meropenem in critically ill patients

1 reference

12 December 2020

A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides.

1 reference

12 December 2020

Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoxime.

1 reference

12 December 2020

Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis

1 reference

12 December 2020

Intrapatient variation of aminoglycoside pharmacokinetics in critically ill surgery patients

1 reference

12 December 2020

The pharmacodynamics of beta-lactams

1 reference

12 December 2020

Should quinolones be used in the treatment of bacterial infections in neutropenic patients?

1 reference

12 December 2020

Immunotherapy of sepsis

1 reference

12 December 2020

Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing.

1 reference

12 December 2020

Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis

1 reference

12 December 2020

What do we really know about antibiotic pharmacodynamics?

1 reference

12 December 2020

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

12 December 2020

Is the end-game penetration (of the airway)?

1 reference

12 December 2020

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia

1 reference

12 December 2020

Once-daily aminoglycoside therapy

1 reference

12 December 2020

Pharmacodynamics of fluoroquinolones.

1 reference

12 December 2020

Gentamicin dosage requirements: wide interpatient variations in 242 surgery patients with normal renal function

1 reference

12 December 2020

Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man.

1 reference

12 December 2020

Continuous infusion of beta-lactam antibiotics

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

12 December 2020

Concept of empiric therapy with antibiotic combinations. Indications and limits

1 reference

12 December 2020

Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital

1 reference

12 December 2020

Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides

1 reference

12 December 2020

Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection

1 reference

12 December 2020

Changes in vancomycin pharmacokinetics in critically ill infants

1 reference

12 December 2020

Pharmacokinetics of cefoperazone: a review

1 reference

12 December 2020

Intermittent bolus dosing of ceftazidime in critically ill patients.

1 reference

12 December 2020

Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis

1 reference

12 December 2020

Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate

1 reference

12 December 2020

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

12 December 2020

Impact of dosage schedule of antibiotics on the treatment of serious infections

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

1 reference

12 December 2020

Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem

1 reference

12 December 2020

Altered pharmacokinetics of ceftazidime in critically ill patients

1 reference

12 December 2020

Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations

1 reference

12 December 2020

Penetration of vancomycin into human lung tissue

1 reference

12 December 2020

Pharmacodynamics of antiinfective therapy: taking what we know to the patient's bedside

1 reference

12 December 2020

A primer on continuous renal replacement therapy for critically ill patients

1 reference

12 December 2020

Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units)

1 reference

12 December 2020

Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes

1 reference

12 December 2020

Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?

1 reference

12 December 2020

Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock

1 reference

12 December 2020

Preventive effect of betamipron on nephrotoxicity and uptake of carbapenems in rabbit renal cortex.

1 reference

12 December 2020

Continuous infusion ceftazidime in intensive care: a randomized controlled trial

1 reference

12 December 2020

Subtleties of antibiotic dosages--do doses and intervals make a difference in the critically ill?

1 reference

12 December 2020

Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy

1 reference

12 December 2020

Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy

1 reference

12 December 2020

Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem.

1 reference

12 December 2020

Fluid shifts have no influence on ciprofloxacin pharmacokinetics in intensive care patients with intra-abdominal sepsis

1 reference

12 December 2020

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

12 December 2020

Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance

1 reference

12 December 2020

1 reference

12 December 2020

Clinical pharmacokinetics during continuous haemofiltration

1 reference

12 December 2020

The use of a change in gentamicin clearance as an early predictor of gentamicin-induced nephrotoxicity

1 reference

12 December 2020

Aminoglycoside volume of distribution and illness severity in critically ill septic patients

1 reference

12 December 2020

Pharmacodynamics, pharmacokinetics, and therapeutic drug monitoring of glycopeptides

1 reference

12 December 2020

Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies

1 reference

12 December 2020

Postantibiotic effects

1 reference

12 December 2020

Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study

1 reference

12 December 2020

Comparative pharmacokinetics of the carbapenems: clinical implications

1 reference

12 December 2020

The pharmacokinetics of the interstitial space in humans

1 reference

12 December 2020

Bacteremic sepsis in intensive care: temporal trends in incidence, organ dysfunction, and prognosis

1 reference

12 December 2020

Intermittent and continuous ceftazidime infusion for critically ill trauma patients

1 reference

12 December 2020

Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics: the minimum inhibitory concentration versus stationary concentration.

1 reference

12 December 2020

Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients

1 reference

12 December 2020

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

1 reference

12 December 2020

The epidemiology of sepsis in the United States from 1979 through 2000

1 reference

12 December 2020

The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients

1 reference

12 December 2020

Pharmacokinetic and experimental data on beta-lactam antibiotics in the treatment of patients

1 reference

12 December 2020

Vancomycin and novobiocin

1 reference

12 December 2020

Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model.

1 reference

12 December 2020

The international sepsis forum consensus conference on definitions of infection in the intensive care unit

1 reference

12 December 2020

Pharmacokinetics of a 3 mg/kg body weight loading dose of gentamicin or tobramycin in critically ill patients

1 reference

12 December 2020

Cost analysis of continuous versus intermittent infusion of piperacillin-tazobactam: a time-motion study

1 reference

12 December 2020

Continuous versus intermittent cefepime infusion in critical care. Preliminary results

1 reference

12 December 2020

Imipenem/cilastatin: pharmacokinetic profile in renal insufficiency

1 reference

12 December 2020

Intrapulmonary pharmacokinetics of linezolid

1 reference

12 December 2020

Alternative dosing strategy for aminoglycosides: impact on efficacy, nephrotoxicity, and ototoxicity.

1 reference

12 December 2020

Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors

1 reference

12 December 2020

Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli

1 reference

12 December 2020

Populations at risk for penicillin-induced seizures

1 reference

12 December 2020

Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis

1 reference

12 December 2020

Pharmacokinetics of continuous renal replacement therapy

1 reference

12 December 2020

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid

1 reference

12 December 2020

Postantibiotic effect of imipenem on Pseudomonas aeruginosa

1 reference

12 December 2020

Variability in aminoglycoside pharmacokinetics in critically ill surgical patients

1 reference

12 December 2020

Pharmacokinetics of piperacillin-tazobactam: intermittent dosing versus continuous infusion

1 reference

12 December 2020

Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia

1 reference

12 December 2020

Once-daily dosing of aminoglycoside antibiotics

1 reference

12 December 2020

Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis

1 reference

12 December 2020

Pharmacological principles of antibiotic prescription in the critically ill.

1 reference

12 December 2020

Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli

1 reference

12 December 2020

Pharmacokinetics of vancomycin in patients with various degrees of renal function

1 reference

12 December 2020

Antimicrobial activity and pharmacokinetics/pharmacodynamics of the novel glycylcycline, tigecycline

1 reference

12 December 2020

Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria

1 reference

12 December 2020

In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis

1 reference

12 December 2020

Renal replacement therapy for the critically ill--precarious progress. Part II. Technical aspects and clinical application

1 reference

12 December 2020

Pharmacokinetics of meropenem in subjects with renal insufficiency

1 reference

12 December 2020

Norepinephrine and vital organ blood flow

1 reference

12 December 2020

Use of antibacterial agents in renal failure

1 reference

12 December 2020

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

1 reference

12 December 2020

The pharmacokinetics of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens

1 reference

12 December 2020

Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections

1 reference

12 December 2020

Continuous infusion of beta-lactam antibiotics

1 reference

12 December 2020

The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimens

1 reference

12 December 2020

A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.

1 reference

12 December 2020

Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome

1 reference

12 December 2020

Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clini

1 reference

12 December 2020

Dose-ranging pharmacokinetic study of ciprofloxacin after 200-, 300-, and 400-mg intravenous doses

1 reference

12 December 2020

Cardiac dysfunction in sepsis: new theories and clinical implications.

1 reference

12 December 2020

Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life

1 reference

12 December 2020

Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa

1 reference

12 December 2020

The pharmacokinetic and pharmacodynamic properties of vancomycin

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects

1 reference

12 December 2020

Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections.

1 reference

12 December 2020

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

1 reference

12 December 2020

Optimizing outcomes with antimicrobial therapy through pharmacodynamic profiling

1 reference

12 December 2020

What is the evidence for once-daily aminoglycoside therapy?

1 reference

12 December 2020

Pharmacokinetic profiles of high-dose intravenous ciprofloxacin in severe sepsis. The Baragwanath Ciprofloxacin Study Group

1 reference

12 December 2020

Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimens

1 reference

12 December 2020

Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

12 December 2020

Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia

1 reference

12 December 2020

10.2165/00003088-200645080-00001

Identifiers

DOI

1 reference

PubMed ID

16884316

Dimensions Publication ID

14 August 2017

0 references

1 reference

PubMed ID

16884316